Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Allergy & Immunology
•
Asthma
Do you utilize urinary leukotrienes as a marker for initiation of montelukast?
Answer from: at Academic Institution
No, I don’t. It is not readily available clinically and has not been shown to be predictive of response.
Sign in or Register to read more
23597
Related Questions
What is the rationale/evidence to support doing 4 puffs of albuterol vs. 2 puffs for a reversibility study?
Have you observed adverse mental health side effects in patients who start montelukast?
Should a patient on medium-dose ICS/LABA with normal PFTs, but who shows a greater than 10% decrease in FEV1 if their PFTs are done after 24 hours off their inhaler, be started on a biologic?
Is there a specific group of children that you start on AIT for prevention of asthma?
Has anyone incidentally diagnosed IgA deficiency in a patient who does not present with any recurrent infections?
What is your approach to distinguishing a Jarisch-Herxheimer reaction from a delayed anaphylactoid reaction?
In light of recent measles outbreaks in the US, would you recommend an MMR booster for an immunocompetent patients born before 1957?
What type of DES should you opt for if a patient has or is concerned about possible nickel allergy?
Do you generally favor nebulizers, HFAs or other devices in children aged 5 and younger with asthma?
Have you experienced any issues with Alvesco inhalers getting clogged repeatedly?